New Teva Generics

Sorafenib Tablets, USP

Brand Equivalent:
Nexavar® tablets
Launch Date:
1/3/2023

Lubiprostone Capsules

Brand Equivalent:
Amitiza® capsules
Launch Date:
1/3/2023

Icosapent Ethyl Capsules

Brand Equivalent:
Vascepa® Capsules
Launch Date:
12/15/2022
New Strength:
1 g

Penciclovir Cream

Brand Equivalent:
Denavir® Cream
Launch Date:
11/14/2022

Naproxen Sodium Extended-Release Tablets

Brand Equivalent:
Naprelan® Controlled-Release Tablets
Launch Date:
11/1/2022
New Strength:
750 mg

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution

Brand Equivalent:
Combigan®
Launch Date:
10/7/2022

Levothyroxine Sodium Tablets, USP

Brand Equivalent:
Synthroid®
Launch Date:
9/21/2022

Pantoprazole Sodium for Injection

Brand Equivalent:
Protonix® I.V. (pantoprazole sodium) for Injection
Launch Date:
9/9/2022

Tacrolimus Ointment

Brand Equivalent:
Protopic® (tacrolimus) Ointment
Launch Date:
9/9/2022

Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals)

Brand Equivalent:
Macrobid® (Nitrofurantoin Capsules, USP) (monohydrate/macrocrystals)
Launch Date:
9/9/2022

Mycophenolate Mofetil Tablets

Brand Equivalent:
CellCept® (mycophenolate mofetil) Tablets
Launch Date:
9/9/2022

Looking for a different generic product?

View Teva's entire generics catalog